For instance, in a cohort of 139 individuals, 82.8% of those with ABCG1 promoter hypermethylation were found to have CHD, whereas only 17.4% of individuals without hypermethylation exhibited the condition. The gene discussed is ABCG1; the disease is coronary artery disorder.